Literature DB >> 29780750

The LuxS/AI-2 Quorum-Sensing System of Streptococcus pneumoniae Is Required to Cause Disease, and to Regulate Virulence- and Metabolism-Related Genes in a Rat Model of Middle Ear Infection.

Mukesh K Yadav1,2, Jorge E Vidal3, Yoon Y Go1, Shin H Kim1, Sung-Won Chae1, Jae-Jun Song1.   

Abstract

Objective:Streptococcus pneumoniae colonizes the nasopharynx of children, and from nasopharynx it could migrate to the middle ear and causes acute otitis media (AOM). During colonization and AOM, the pneumococcus forms biofilms. In vitro biofilm formation requires a functional LuxS/AI-2 quorum-sensing system. We investigated the role of LuxS/AI-2 signaling in pneumococcal middle ear infection, and identified the genes that are regulated by LuxS/AI-2 during pneumococcal biofilm formation.
Methods: Streptococcus pneumoniae D39 wild-type and an isogenic D39ΔluxS strain were utilized to evaluate in vitro biofilm formation, and in vivo colonization and epithelial damage using a microtiter plate assay and a rat model of pneumococcal middle ear infection, respectively. Biofilm structures and colonization and epithelial damage were evaluated at the ultrastructural level by scanning electron microscopy and confocal microscopy. Microarrays were used to investigate the global genes that were regulated by LuxS/AI-2 during biofilm formation.
Results: The biofilm biomass and density of D39ΔluxS were significantly (p < 0.05) lower than those of D39 wild-type. SEM and confocal microscopy revealed that D39ΔluxS formed thin biofilms in vitro compared with D39 wild-type. The in vivo model of middle ear infection showed that D39ΔluxS resulted in ~60% less (p < 0.05) bacterial colonization than the wild-type. SEM analysis of the rat middle ears revealed dense biofilm-like cell debris deposited on the cilia in wild-type D39-infected rats. However, little cell debris was deposited in the middle ears of the D39ΔluxS-inoculated rats, and the cilia were visible. cDNA-microarray analysis revealed 117 differentially expressed genes in D39ΔluxS compared with D39 wild-type. Among the 66 genes encoding putative proteins and previously characterized proteins, 60 were significantly downregulated, whereas 6 were upregulated. Functional annotation revealed that genes involved in DNA replication and repair, ATP synthesis, capsule biosynthesis, cell division, the cell cycle, signal transduction, transcription regulation, competence, virulence, and carbohydrate metabolism were downregulated in the absence of LuxS/AI-2.
Conclusion: The S. pneumoniae LuxS/AI-2 quorum-sensing system is necessary for biofilm formation and the colonization of the ear epithelium, and caused middle ear infection in the rat model. LuxS/AI-2 regulates the expression of the genes involved in virulence and bacterial fitness during pneumococcal biofilm formation.

Entities:  

Keywords:  LuxS/AI-2; Streptococcus pneumoniae; biofilm; in vivo colonization; luxS mutation; quorum-sensing

Mesh:

Substances:

Year:  2018        PMID: 29780750      PMCID: PMC5945837          DOI: 10.3389/fcimb.2018.00138

Source DB:  PubMed          Journal:  Front Cell Infect Microbiol        ISSN: 2235-2988            Impact factor:   5.293


Introduction

Otitis media (OM) is one of the main reasons antibiotics are prescribed for children in both developing and developed countries (Grijalva et al., 2009; Arguedas et al., 2010). More than 80% of children up to the age of 3 year experience at least one episode of acute OM (AOM), and the health and economic burdens associated with AOM are significant (Pichichero, 2013; Usonis et al., 2016). Streptococcus pneumoniae (S. pneumoniae) is the most important bacteria that causes AOM in children (Bergenfelz and Hakansson, 2017). Although S. pneumoniae can cause disease, it is a commensal bacterium that quiescently and asymptomatically colonizes the mucosal surface of the nasopharynx in the form of a specialized structure called a biofilm (Bogaert et al., 2004; Simell et al., 2012). Once established as a biofilm, the bacteria can disperse to other typically sterile anatomical sites and cause pneumonia, OM, bacteremia, or meningitis (Hall-Stoodley et al., 2006; Sanchez et al., 2010; Weimer et al., 2010; Ash and Sheffield, 2013; Pichichero, 2013; Shak et al., 2013). It has been suggested that pneumococcal biofilms can also asymptomatically colonize the mucosal surfaces of the middle ear (during OM) and sinuses (during rhinosinusitis) (Hall-Stoodley et al., 2006; Sanderson et al., 2006; Hoa et al., 2009). During colonization and biofilm formation, the pneumococci replicate slowly and express low levels of virulence factors, such as the polysaccharide capsule. They also produce extracellular DNA, proteins, lipids, and polysaccharides. The bacteria within biofilms are embedded in a self-produced extracellular polymeric substance (EPS) matrix, and are resistant to both host immune defenses and antibiotics (Donlan and Costerton, 2002). More frequent genetic transformation has also been detected in biofilms. The available DNA in the biofilm matrix serves as a substrate for transformation that can result in the evolution of resistant strains and the spread of drug-resistant genotypes (Trappetti et al., 2011c; Vidal et al., 2011; Croucher et al., 2012; Chao et al., 2014). It has been reported that the changes observed in pneumococcal transcription during biofilm formation are also associated with colonization (Sanchez et al., 2011). Furthermore, bacteria dispersed in biofilms have an increased propensity for tissue dissemination and pathogenesis compared with bacteria in free-floating, planktonic culture (Marks et al., 2013; Chao et al., 2014). The biofilm mode of growth provides an opportunity for pneumococci to colonize the upper respiratory tract and persist without causing disease; thus, pneumococcal carriage is common (Simell et al., 2012; Shak et al., 2013; Gilley and Orihuela, 2014). The persistence, pathogenesis, and drug resistance of pneumococcal biofilms is of high clinical importance. During biofilm formation, bacteria regulate gene expression in response to changes in population density through a mechanism called quorum sensing (QS) (Hense et al., 2007). QS is mediated by secreted molecules called auto-inducers (AIs). One of these, a furanosyl borate diester called AI-2, is a metabolic byproduct of a luxS gene-encoded synthase: an enzyme involved primarily in the conversion of ribosyl-homocysteine into homocysteine and 4,5-dihydroxy-2,3-pentanedione (DPD), which is the precursor of AI-2 (Chen et al., 2002; Trappetti et al., 2011a). Various studies have shown that LuxS regulates pneumococcal biofilm formation, competence, and autolysis (Trappetti et al., 2011c; Vidal et al., 2011). Previous studies using a mouse model of pneumococcal colonization suggest that LuxS plays an important role in persistence in the nasopharynx (Joyce et al., 2004). It has also been reported that S. pneumoniae luxS mutant strain has low in vitro biofilm formation capacity, and is defective in genetic competence and iron uptake (Trappetti et al., 2011c; Vidal et al., 2011, 2013). Using a mouse model of intranasal challenge, Stroeher et al. (2003) demonstrated that the ability to spread from the nasopharynx to the lungs or blood was reduced in an S. pneumoniae D39 luxS mutant compared with the wild-type D39 strain (Stroeher et al., 2003). More recently, it has been reported that LuxS/AI-2 signaling enables pneumococci to use galactose as a carbon source, and enhances capsular polysaccharide production and the hyper-virulent phenotype (Trappetti et al., 2017). However, the role of the LuxS/AI-2 QS system in the global gene expression of pneumococcal biofilms, and in the in vivo colonization of the rat middle ear has not been reported. Therefore, in the present study we confirmed that LuxS/AI-2 is necessary for in vitro biofilm formation, analyzed its ultrastructure by electron microscopy, and assessed the effects of the absence of LuxS/AI-2 signaling on pneumococcal middle ear infection. We used a rat model of pneumococcal middle ear infection for the in vivo studies, and ultimately identified the global genes that are regulated by LuxS/AI-2 during pneumococcal biofilm formation.

Materials and methods

Ethics statement

The animal experiment protocol was approved by the Institute Review Board of Korea University, Guro Hospital, Seoul, South Korea. The animal experiments were carried out as per the guidelines provided by the Animal Research Committee, Korea University College of Medicine, Seoul, South Korea.

Bacterial strains and culture media

Streptococcus pneumoniae D39 (NCTC 7466) was obtained from the Health Protection Agency Culture Collection (Salisbury, UK). It is Avery's Virulent Serotype 2 encapsulated strain, and is extremely virulent in animal models of infection (Avery et al., 1944). The S. pneumoniae luxS mutant strain (D39ΔluxS) has been prepared and characterized in previous studies (Vidal et al., 2011, 2013). The S. pneumoniae strains were grown on blood agar plates (BAPs) (Shin Yang Chemicals Co., Ltd., Seoul, Korea) and in brain heart infusion (BHI) broth.

In vitro biofilm formation abilities of S. pneumoniae D39 wild-type and D39ΔluxS

The in vitro biofilm formation abilities of S. pneumoniae D39 wild-type and an isogenic D39ΔluxS strain were evaluated using a static microtiter plate assay, as described previously (Christensen et al., 1982; Yadav et al., 2017b). Briefly, the pneumococcal strains were grown on BAPs overnight. A single colony from each plate was transferred to BHI broth and grown to the mid-exponential phase. The log-phase cells were diluted (1:200), and 1 mL of each cell suspension was seeded into a 24-well polystyrene flat-bottomed microtiter plate (BD Falcon, Sparks, MD, USA), and incubated at 37°C for various times. After incubation, the planktonic cells and medium were removed, and the biofilms remaining in the wells were washed twice with phosphate-buffered saline (PBS). The biofilms were then stained with 200 μL of 0.1% crystal violet (CV) for 15 min. After staining, the plates were washed twice with PBS and air-dried. The CV in the wells was dissolved in 1 mL of ethanol, 200 μL of the CV solution from each well was transferred to a 96-well plate, and the absorbance at 570 nm was measured using a micro-plate reader. Alternative, the viable bacterial within the biofilms were detected by cfu counting. The biofilms were washed twice with PBS and suspended by sonication in 1 mL of PBS. The resulting biofilm suspensions were serially diluted and plated onto BAPs, and the bacteria were counted after overnight incubation at 37°C.

Effect of incubation time on the in vitro biofilm growth of S. pneumoniae D39 wild-type and D39ΔluxS

It has been reported that S. pneumoniae biofilms are affected by incubation time. Therefore, to evaluate the effect of incubation time on in vitro biofilm formation, we grew S. pneumoniae D39 wild-type and D39ΔluxS biofilms for various times (6, 12, 18, and 24 h). We then determined biofilm biomass using a CV-microtiter assay, as described above.

Scanning electron microscopy (SEM) analysis of in vitro biofilms formed by the S. pneumoniae D39 wild type and D39ΔluxS

We investigated the morphologies of the in vitro-formed biofilms of the D39 wild-type and the D39ΔluxS strains using SEM. The biofilms were grown for 18 h, as described above. After incubation, the biofilms were washed with PBS, and fixed with 2% glutaraldehyde and 2.5% paraformaldehyde. The biofilms were then treated with 1% osmic acid for 2 h, and dehydrated with a graded series of ethanol (60–95%). Biofilm samples were washed thrice with t-butyl alcohol (Sigma, St. Louis, MO, USA), and preserved under freezing conditions. The biofilm samples were freeze-dried using ES-2030 equipment (Hitachi, Tokyo, Japan), and coated with platinum using an ion coater (IB-5; Eiko, Kanagawa, Japan). SEM images were captured by field emission-SEM (FE-SEM, S-4700; Hitachi, Tokyo, Japan).

Confocal microscopy of S. pneumoniae D39 wild-type and D39ΔluxS biofilms

Streptococcus pneumoniae D39 wild-type and D39ΔluxS biofilms were evaluated by confocal microscopy. The biofilms were grown on μ-slides (ibidi, Germany) for 18 h using the procedure described above. After incubation, the biofilms were stained using a LIVE/DEAD biofilm viability kit (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. After washing with PBS, the stained biofilms were examined using a Nikon A1 confocal microscope (Nikon Instruments, Inc., NY, USA) with fluorescein (green) and Texas red (red) band-pass filter sets.

Evaluation of the in vivo colonization capability of the S. pneumoniae D39 wild-type and D39ΔluxS

The in vivo colonization capability of the D39 wild-type and D39ΔluxS strains was evaluated using a rat model of OM (Yadav et al., 2012b, 2017a). Twenty healthy, pathogen-free Sprague Dawley (SD) rats weighing approximately 150–200 g were purchased from Koatech (Pyeongtaek, South Korea). All rats were housed isolated under sterile conditions for 2 weeks prior to the start of the experiments, and were examined for abnormalities in the middle ear. They were then divided into four groups: the rats in group 1 (n = 7) were inoculated with S. pneumoniae D39 wild-type; the rats in group 2 (n = 7) were inoculated with S. pneumoniae D39ΔluxS; the rats in group 3 (n = 3) received the medium only (vehicle control); and the rats in group 4 (n = 3) received no treatment (no procedure control). The rats were anesthetized with a combination of Zoletil H (tiletamine-zolazepam; Virbac, Carros, France) and Rompun H (xylazine-hydrochloride; Bayer, Leverkusen, Germany) at a ratio of 1:1. The bacteria suspensions containing the S. pneumoniae wild-type or ΔluxS strain were prepared in BHI medium, and 50 μL (~1 × 107 colony-forming units (CFUs)) of the suspension (or medium only) was injected into the right middle ear of each rat in groups 1 (wild-type), 2 (ΔluxS), and 3 (medium) through the tympanic membrane (trans-tympanic membrane inoculation) using a tuberculin syringe and a 27-gauge needle. The rats were monitored daily for 1 week for abnormalities. The rats were then sacrificed, and bullae were acquired aseptically. The tympanic membranes and upper tissues were removed, and the middle ears were dissected and photographed. For the SEM analysis, representative bullae from each group were cleaned by trimming the bony parts so that the middle ear was clearly visible, and were preserved in SEM solution (glutaraldehyde and paraformaldehyde). To determine the number of viable bacteria, bullae from each group were aseptically homogenized with a mortar and pestle, serially diluted in PBS, and plated on BAP. After incubation at 37°C for 24 h, S. pneumoniae colonies were counted, and CFUs were calculated.

Differential gene expression analysis of in vitro biofilms of S. pneumoniae D39 wild-type or D39ΔluxS

The global gene expression of S. pneumoniae D39 wild-type and D39ΔluxS biofilms were determined using a cDNA-microarray. For the experiment, S. pneumoniae D39 wild-type and D39ΔluxS biofilms were grown in 24-well plates for 18 h, as described above. The biofilms were washed twice with PBS, scraped, and suspended in PBS. The biofilm cells were then pelleted by centrifugation and treated with 100 μL of lysozyme [3 mg/mL in Tris-ethylenediaminetetraacetic acid (EDTA) buffer (TE); Sigma-Aldrich, St. Louis, MO, USA] for 4 min to lyse the cells. Total RNA was extracted using an RNeasy Total RNA Isolation System Kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. Contaminating DNA was removed by on-column RNase-free DNase (Qiagen) treatment for 10 min at 20–25°C. The quantity and quality of total RNA was detected using a NanoDrop (NanoDrop Technologies, Inc., Wilmington, DE, USA), and the integrity of the RNA was assessed using Bioanalyzer 2100 equipment (Agilent, Palo Alto, CA, USA). RNA probe synthesis and hybridization were performed using the Agilent Low Input Quick Amp WT Labeling Kit according to the manufacturer's protocol. Briefly, 200 ng of total biofilm RNA was mixed with WT primer mix, and the samples were incubated at 65°C for 10 min. The cDNA master mix was then prepared with 5 × first strand buffer, 0.1 M dithiothreitol, 10 mM dNTP mix, and RNase Block Mix (AffinityScript), and added to the RNA + WT primer reaction mixture. The samples were incubated at 40°C for 2 h, and reverse transcription and dsDNA synthesis were terminated by incubation at 70°C for 15 min. The transcription master mix was prepared according to the manufacturer's protocol (5 × transcription buffer, 0.1 M dithiothreitol, NTP mix, T7-RNA polymerase blend, and cyanine 5-CTP in nuclease-free water). The transcription of dsDNA was performed by adding transcription master mix to the dsDNA reaction samples and incubating the mix at 40°C for 2 h. The amplified and labeled cRNA was purified on an RNase mini column (Qiagen) according to the manufacturer's protocol. The labeled complementary RNA (cRNA) target was quantified using an spectrophotometer. After checking the labeling efficiency of the cyanine 5-labeled cRNA target, the cRNA was fragmented by adding 10 × blocking agent and 25 × fragmentation buffer, and incubating at 60°C for 30 min. The fragmented cRNA was resuspended in 2 × hybridization buffer and directly pipetted onto an assembled S.pneumoniae_6 x 7k V2 Microarray (mycroarray.com). The arrays were hybridized at 57°C for 17 h in an Agilent Hybridization oven. The hybridized microarrays were washed according to the manufacturer's washing protocol (Agilent Technology). After overnight incubation at 42°C, the slides were washed twice with washing solution 1 (containing 2 × saline-sodium citrate buffer (SSC) and 0.1% sodium dodecyl sulfate) for 5 min at 42°C, washed once with washing solution 2 (containing 0.1 × SSC and 0.1% sodium dodecyl sulfate) for 10 min at room temperature, and finally washed four times with 0.1 × SSC for 1 min at room temperature. The slides were dried by centrifugation at 650 rpm for 5 min. The hybridization image on the slide was scanned using 4000B apparatus (Axon Instruments, Union City, CA, USA). The hybridization images were analyzed using GenePix Pro 3.0 software (Axon Instruments, Union City, CA, USA) to obtain the gene expression ratios of the D39 wild-type and D39ΔluxS biofilms. The microarray data were analyzed using Genowiz 4.0™ (Ocimum Biosolutions, Hyderabad, India), and normalized with Global LOWESS. The cutoffs for upregulated and downregulated genes were +2-fold and−2-fold, respectively. The microarray experiment was performed with three biological replicates. Statistical significance was calculated using Student's t-test, and p-values < 0.05 were considered significant. STRING version 10.5 (https://string-db.org) was used for functional annotation, and the UniProtKB database (http://www.uniprot.org/uniprot/P0A4M0) was used to search for clusters of biological processes in the gene ontology database within the two sets of differentially expressed genes (D39ΔluxS and D39 wild-type). The microarray data have been deposited in the National Center for Biotechnology Information (NCBI)'s Gene Expression Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/geo/info/linking.html), and are accessible through GEO Series accession number GSE109347.

Real-time reverse transcription polymerase chain reaction (RT-PCR) analysis

To confirm the microarray data by real-time RT-PCR, we chose 15 genes that are differentially expressed in biofilms, and the 16S gene as a control. The primer sequences are presented in Table 1. Each 20-μL real-time RT-PCR reaction mixture included 10 μL of 2 × SYBR Green PCR Master Mix (Roche Applied Science, Indianapolis, IN, USA), 5 pmol each of the forward and reverse primers, and 2 μL of complementary DNA (cDNA). The PCR conditions were: an initial denaturation step at 95°C for 10 min, followed by 40 cycles of denaturation at 95°C for 15 s, and annealing and extension at 60°C for 1 min. Negative controls, which contained nuclease-free water instead of RNA, were included to confirm that the samples were free from contamination. To verify the absence of contaminating genomic DNA, each RT-PCR experiment included a no reverse transcriptase control. Relative gene expression was determined using the 2−ΔΔCT method. The reference gene was 16S, and the standard condition was the D39 wild-type biofilm.
Table 1

List of primers used in the present study.

Serial numberGenePrimer sequencesAmplicon size (base pair)
116s5′-AACCAAGTAACTTTGAAAGAAGAC-′3126
5′-AAATTTAGAATCGTGGAATTTTT-′3
2ply5′-TGAGACTAAGGTTACAGCTTACAG-′3225
5′-CTAATTTTGACAGAGAGATTACGA-′3
3lytA5′-AGTTTAAGCATGATATTGAGAAC-′3272
5′-TTCGTTGAAATAGTACCACTTAT-′3
4ccpA5′- GACAGGAAAAGGAATGAATGC-3′116
5′- GGAAACACCTGCTTCACGAG-3′
5lacG-25′-ACTAGCTGGTTCGGCAGTGT-3′102
5′-GCTTATCAAGCAGAAGGTGCT-3′
6rnr5′-GCCTGATTTGACTCTTCGTG−3′70
5′-ACGGATACGGATCTGCTGAC−3′
7argG5′-AAATCGCTTGGTTGGGATTA-3′100
5′-CACAAGCGTCAAGTCCTCAA-3′
8comX25′-GGCATGGTCTGCTTATTACATGA-3′99
5′-TCGATTTCGAAACTTGGTTTT-3′
9mtnN5′-TTGCTGCTATGCCAGAAGAA-3′76
5′-TTCCCCAAAACAACTTGCTC-3′
10cysK5′-ACTGGTGGAACGATTTCTGG-3′119
5′-TGAGGACCAGGTTTTTCACC-3′
11ciaR5′-TGGATTTGATGTTGCCAGAA-3′145
5′-TAATCATCCGCTCCCAGTTC-3′
12aliA5′-ATTGCCTTTGGTTTTGATCG-3′173
5′-TCCTTCCATTCATCCCCATA-3′
13SufB5′-GCTAAGGGTGAGCCTGAGTG-3′150
5′-GGCTGGTTTGTCAGATGGTT-3′
14blpU5′-GATTTTGCCAAAGCAGGTGT-3′127
5′-CATAGGCCACACCTCCAAGT-3′
15glmU5′-GGACACAAGGCAGAATTGGT-3′150
5′-ATCTCCTGCAATGACCAAGG-3′
16rafE5′-CGAAGGATGTCCATGACCTT-3′161
5′-GCAGATGCTTGGACACTCAA-3'
List of primers used in the present study.

Results

The luxS mutant strain formed less biofilm in vitro

It has been reported that the LuxS/AI-2 QS system regulates biofilm formation in S. pneumoniae. In the present study, we compared the planktonic growth and biofilm formation capability of S. pneumoniae D39 wild-type and the isogenic D39ΔluxS strain. No significant difference in the density of planktonic cells was observed between the D39 wild-type and D39ΔluxS strains (Figure 1A). After 18 h, the biofilm biomass of D39ΔluxS was significantly (p < 0.05) lower than that of the D39 wild-type when it was analyzed using the CV microplate assay (Figure 1B), or by bacterial counts (Figure 1C).
Figure 1

Streptococcus pneumoniae D39 wild-type and D39ΔluxS planktonic and biofilm growth. (A) Planktonic growth optical density at 600 nm. (B) Quantification of biomass of in vitro biofilms grown for 18 h, using a CV-microplate assay. (C) Colony-forming unit (CFU) counts of in vitro biofilms grown for 18 h. Error bars are the standard deviation from the mean. Statistical significance was calculated using the Student's t-test, *p < 0.05.

Streptococcus pneumoniae D39 wild-type and D39ΔluxS planktonic and biofilm growth. (A) Planktonic growth optical density at 600 nm. (B) Quantification of biomass of in vitro biofilms grown for 18 h, using a CV-microplate assay. (C) Colony-forming unit (CFU) counts of in vitro biofilms grown for 18 h. Error bars are the standard deviation from the mean. Statistical significance was calculated using the Student's t-test, *p < 0.05. We then conducted a time-course experiment to evaluate the effect of the absence of the luxS gene at various stages of biofilm formation. The results revealed a significant (p < 0.05) decrease in biofilm biomass in D39ΔluxS at 6, 12, 18, and 24 h post-inoculation (Figure 2). The results revealed that the D39ΔluxS mutant formed significantly less biofilm biomass than the D39 wild-type at all time-points.
Figure 2

In vitro biofilm growth of Streptococcus pneumoniae D39 wild-type and D39ΔluxS strains at different time-points after inoculation (6, 12, 18, and 24 h). The error bars are the standard deviation from the mean. Statistical significance was calculated using the Student's t-test, *p < 0.05.

In vitro biofilm growth of Streptococcus pneumoniae D39 wild-type and D39ΔluxS strains at different time-points after inoculation (6, 12, 18, and 24 h). The error bars are the standard deviation from the mean. Statistical significance was calculated using the Student's t-test, *p < 0.05.

SEM revealed thin and scattered biofilms formed by the luxS mutant strain

We used SEM to investigate the morphologies of the D39 wild-type and D39ΔluxS biofilms grown for 18 h. The SEM analysis revealed that the D39 wild-type strain formed thick, three-dimensionally (3D) organized heterogeneous biofilms. The cells in the D39 wild-type biofilms were surrounded by extracellular polysaccharides (EPS), and were attached to both the bottom of the plate and to each other, forming an organized 3D biofilm structure with significant depth (Figures 3A–C). In contrast, the biofilms formed by D39ΔluxS were thin and disorganized. The cells were attached only to the base of the plate, and no cell–cell adherence was observed (Figures 3D–F). The cell surfaces were smooth and devoid of EPS.
Figure 3

Scanning electron microscopy (SEM) images of Streptococcus pneumoniae in vitro biofilms grown for 18 h. (A–C) are representative SEM images of the D39 wild-type strain. The wild-type strain biofilms were thick and organized with a significant depth. (D–F) are SEM images of the D39ΔluxS strain. The D39ΔluxS biofilms were thin and disorganized, and extracellular polymeric substance (EPS) was absent.

Scanning electron microscopy (SEM) images of Streptococcus pneumoniae in vitro biofilms grown for 18 h. (A–C) are representative SEM images of the D39 wild-type strain. The wild-type strain biofilms were thick and organized with a significant depth. (D–F) are SEM images of the D39ΔluxS strain. The D39ΔluxS biofilms were thin and disorganized, and extracellular polymeric substance (EPS) was absent.

Confocal microscopy of in vitro biofilms formed by the D39ΔluxS mutant and D39 wild-type strains

We investigated the D39ΔluxS and D39 wild-type biofilms grown for 18 h in vitro using a confocal microscope. Confocal microscopy revealed a significant difference in the morphology of the biofilms formed by the D39ΔluxS and D39 wild-type strains. The D39 wild-type biofilms were compact, thick, and had a well-organized 3D structure (Figure 4A). In contrast, the D39ΔluxS biofilms were thin with scattered pneumococci attached to the bottom of the dish. Their 3D structure was disorganized (Figure 4B).
Figure 4

Confocal microscopy images of Streptococcus pneumoniae in vitro biofilms grown for 18 h. (A) Confocal microscopy image of the D39 wild-type strain biofilm. (B) Confocal microscopy image of the D39ΔluxS strain biofilm.

Confocal microscopy images of Streptococcus pneumoniae in vitro biofilms grown for 18 h. (A) Confocal microscopy image of the D39 wild-type strain biofilm. (B) Confocal microscopy image of the D39ΔluxS strain biofilm.

A mutation in luxS decreases colonization of S. pneumoniae in the rat middle ear

The in vivo colonization abilities of the D39 wild-type and D39ΔluxS strains were evaluated using a rat model of middle ear infection. At 1 week post-inoculation, the rats were sacrificed, and their bullae were obtained, dissected, and cleaned of unwanted tissue. As Figure 5A shows, the rat bullae inoculated with the D39 wild-type were completely filled with biofilm-like debris, and exhibited severe mucosal swelling (Figure 5A). In contrast, the rat bullae inoculated with D39ΔluxS showed signs of inflammation, with a thick mucosa, but no visible biofilm-like debris (Figure 5B). As expected, the bullae of the control animals were clean, with no signs of inflammation (Figure 5C). The bacterial density in the middle ears of the rats inoculated with D39 wild-type was ~7.04 × 104 (SD ± 26083.2) CFU/bullae, whereas that of the rats inoculated with the D39ΔluxS strain was significantly lower at ~1.85 × 104 (SD ± 8859) CFU/bullae (Figure 5D). The mean CFUs of the D39ΔluxS strain were significantly lower (~60% reduction, p < 0.05) than the CFUs of the D39 wild-type strain.
Figure 5

Digital photos of rat bullae and colony-forming unit (CFU) counts of bullae inoculated with Streptococcus pneumoniae D39 wild-type or D39ΔluxS. (A) Rat bullae inoculated with the D39 wild-type. (B) Rat bullae inoculated with the D39ΔluxS, and (C) Rat bullae inoculated with medium. (D) CFU of S. pneumoniae colonizing the rat middle ear mucosa. Error bars are the standard deviation from the mean. Statistical significance was calculated using the Student's t-test, *p < 0.05.

Digital photos of rat bullae and colony-forming unit (CFU) counts of bullae inoculated with Streptococcus pneumoniae D39 wild-type or D39ΔluxS. (A) Rat bullae inoculated with the D39 wild-type. (B) Rat bullae inoculated with the D39ΔluxS, and (C) Rat bullae inoculated with medium. (D) CFU of S. pneumoniae colonizing the rat middle ear mucosa. Error bars are the standard deviation from the mean. Statistical significance was calculated using the Student's t-test, *p < 0.05. Histologically, the middle ear mucosa comprises both non-ciliated squamous epithelium and ciliated epithelium. The ciliated epithelium is distributed in the hypotympanum and Eustachian tube orifice, whereas the remainder of the middle ear bulla is covered with non-ciliated squamous epithelium. SEM images of a rat middle ear colonized by D39 wild-type are shown in Figures 6A–C. In these images, thick cells or biofilm debris deposits were visible (arrow). Cilia, however, were not visible but were completely covered with biofilm debris (Figures 6A–C). Conversely, in the rat middle ear colonized with D39ΔluxS, less biofilm debris was observed, although the cilia were coagulated (Figures 6D–F). The middle ears of the rats inoculated with vehicle (control) were clean, and neither biofilms nor cell debris were detected (Figures 6G–I).
Figure 6

Scanning electron microscopy (SEM) images of rat bullae inoculated with Streptococcus pneumoniae D39 wild-type and D39ΔluxS. (A–C) are representative SEM images of rat bullae inoculated with the D39 wild-type strain. In rats colonized with the wild-type strain, dense biofilm/cell debris was deposited on the cilia, and the cilia were coagulated and completely covered with biofilm debris. (D–F) are representative SEM images of rat bullae inoculated with the D39ΔluxS strain. In rat bulla colonized with the D39ΔluxS strain, less biofilm debris was visible, although the cilia were coagulated. (G–I) are representative SEM images of rat bullae inoculated with medium (vehicle control). The vehicle control rat bulla were clean.

Scanning electron microscopy (SEM) images of rat bullae inoculated with Streptococcus pneumoniae D39 wild-type and D39ΔluxS. (A–C) are representative SEM images of rat bullae inoculated with the D39 wild-type strain. In rats colonized with the wild-type strain, dense biofilm/cell debris was deposited on the cilia, and the cilia were coagulated and completely covered with biofilm debris. (D–F) are representative SEM images of rat bullae inoculated with the D39ΔluxS strain. In rat bulla colonized with the D39ΔluxS strain, less biofilm debris was visible, although the cilia were coagulated. (G–I) are representative SEM images of rat bullae inoculated with medium (vehicle control). The vehicle control rat bulla were clean.

Differential gene expression in D39 wild-type biofilms and those produced by the D39ΔluxS mutant

The changes in the gene expression levels of the D39ΔluxS mutant biofilm with respect to D39 wild-type were evaluated using a cDNA microarray. Total RNA was extracted from 18-h-old biofilm samples grown in triplicate on a microtiter plate. The cDNA synthesis, labeling, and hybridization were performed as per standard protocols. The hybridization images were analyzed to detect the gene expression ratios in the D39 wild-type and D39ΔluxS biofilms. The fold changes in gene expression of the D39ΔluxS biofilms were detected with respect to the D39 wild-type. The ±2-fold changes in gene expression in the three biological replicate samples were included in this study. The cDNA-microarray analysis demonstrated that 117 genes were differentially expressed in D39ΔluxS compared with the D39 wild-type. According to functional group analysis, 51 of these genes were uncharacterized/hypothetical. Among the 66 genes encoding putative and previously characterized proteins, 60 were significantly downregulated and 6 were significantly upregulated (Table 2). The KEGG pathways of down-regulated genes in biofilms of S. pneumoniae D39ΔluxS with respect to D39 wild-type are shown in Figure 7.
Table 2

List of differentially expressed genes in biofilms of the Streptococcus pneumoniae D39luxS mutant strain compared with the wild-type D39.

Serial numberGene ID and gene nameProtein nameGO-biological processMean fold change in D39ΔluxS
1SPD_0002 (dnaN)DNA polymerase III subunit betaDNA replication−200
2SPD_0013 (ftsH)ATP-dependent zinc metalloprotease FtsHCell division−800
3SPD_0046 (blpU)BacteriocinBlpUDefense response to bacterium−6.45
4SPD_0065 (bgaC)Beta-galactosidase 3Carbohydrate metabolic process−5.9
5SPD_0071 (galM)Aldose 1-epimeraseHexose metabolic process−2.2
6SPD_0110 (argG)Argininosuccinate synthaseArginine biosynthetic process−4.5
7SPD_0195 (rplW)50S ribosomal protein L23Translation−2.1
9SPD_0261 (pepC)Aminopeptidase CAminopeptidase activity−4.76
10SPD_0315 (cps2A)Integral membrane regulatory protein Cps2ADNA replication−2.3
11SPD_0316 (cps2B)Tyrosine-protein phosphatase CpsBProtein tyrosine phosphatase activity−1.75
12SPD_0317 (cps2C)Chain length determinant protein/polysaccharide export protein, MPA1 family proteinLipopolysaccharide biosynthetic process−1.85
13SPD_0318 (cps2D)Tyrosine-protein kinase Cps2D cytosolic ATPase domainExtracellular polysaccharide biosynthetic process−2
14SPD_0319 (cps2E)integral component of membraneUndecaprenylphosphateglucosephosphotransferase Cps2E−1.8
15SPD_0320 (cps2T)Glycosyl transferase, group 1 family proteinTransferase activity−2.4
16SPD_0322 (cps2G)Glycosyl transferase, group 1 family proteinTransferase activity, transferring glycosyl groups−5.26
17SPD_0334 (aliA)Oligopeptide ABC transporterATP-binding cassette (ABC) transporter complex−166
18SPD_0468 (blpR)Response regulator BlpRRegulation of transcription−166
19SPD_0473 (blpY)Immunity protein BlpYIntegral component of membrane−2.7
20SPD_0524 (vncR)DNA-binding response regulator VncRRegulation of transcription−4.5
21SPD_0532 (recJ)Single-stranded-DNA-specific exonuclease RecJDNA repair−200
22SPD_0536 (fibB)Beta-lactam resistance factorCell wall macromolecule biosynthetic process−4.44
23SPD_0578 (pabB)Para-aminobenzoate synthase, component IFolic acid-containing compound biosynthetic process−4.5
24SPD_0598 (murD)UDP-N-acetylmuramoylalanine-d-glutamate ligasePeptidoglycan biosynthetic process4.52
25SPD_0623 (thiM)Hydroxyethylthiazole kinase 1Thiamine biosynthetic process−4.44
26SPD_0654 (livM)Branched-chain amino acid ABC transporter, permease proteinTransporter activity−3.84
27SPD_0701 (ciaR)DNA-binding response regulator CiaRRegulation of transcription−200
28SPD_0700 (pepN)AminopeptidaseAminopeptidase activity−4
29SPD_0766 (sufB)FeS assembly protein SufBIron-sulfur cluster assembly−166
30SPD_0813 (nspC)Carboxynorspermidine decarboxylaseNor-spermidine biosynthetic process−144
31SPD_0833 (gid)Methylenetetrahydrofolate-tRNA-(uracil-5-)-methyltransferase TrmFOtRNA processing−200
32SPD_0862 (rnr)Ribonuclease RNucleic acid binding−142
33SPD_0866 (pepF)Oligoendopeptidase FMetalloendopeptidase activity−5.2
34SPD_0902 (trmE)tRNA modification GTPaseMnmEtRNA modification−108
35SPD_1041 (nrdH)Glutaredoxin-like protein NrdHCell redox homeostasis−150
36SPD_1046 (lacG-2)6-phospho-beta-galactosidaseLactose catabolic process via tagatose-6-phosphate−4.5
37SPD_1047 (lacE-2)PTS system, lactose-specific IIBC componentsPhosphoenolpyruvate-dependent sugar phosphotransferase system−200
38SPD_1052 (lacB)Galactose-6-phosphate isomerase subunit LacBGalactose catabolic process−2
39SPD_1050 (lacD)Tagatose 1,6-diphosphate aldolaselactose catabolic process via tagatose-6-phosphate−2.1
40SPD_1051 (lacC)Tagatose-6-phosphate kinaselactose catabolic process via tagatose-6-phosphate−1.6
41SPD_1053 (lacA)Galactose-6-phosphate isomerase subunit LacAGalactose catabolic process−1.7
42SPD_1083 (vicX)VicX proteinvicX may serve as a rho-independent transcriptional terminator−166
43SPD_1124 (licB)Protein LicBIntegral component of membrane−5
44SPD_1134 (pyrR)Bifunctional protein PyrRRegulation of transcription−166
45SPD_1038 (phpA)Pneumococcal histidine triad protein AMembrane protein−200
46SPD_1292 (ogt)Methylated-DNA–protein-cysteine methyltransferaseDNA dealkylation involved in DNA repair−200
47SPD_1339 (atpF)ATP synthase subunit bATP synthesis coupled proton transport−2.0
48SPD_1341(atpE)ATP synthase subunit cATP hydrolysis coupled proton transport2.26
49SPD_1357 (aliB)Oligopeptide ABC transporter, oligopeptide-binding protein AliBTransmembrane transport−3.78
50SPD_1373 (aspC)AminotransferaseBiosynthetic process−166
51SPD_1381 (def-2)Peptide deformylaseTranslation−5.55
52SPD_1626 (xth)Exodeoxyribonuclease IIIEndonuclease activity−200
53SPD_1642 (proWX)Choline transporter (Glycine betaine transport system permease protein)Transport−1.9
54SPD_1739 (recA)Protein RecADNA repair−5
55SPD_1757 (ndk)Nucleoside diphosphate kinaseATP binding−200
56SPD_1818 (comX2)Transcriptional regulator ComX1DNA-templated transcription, initiation−4.3
57SPD_1993 (fucU)RbsD/FucU transport protein family proteinMonosaccharide metabolic process−200
58SPD_2037 (cysK)Cysteine synthaseCysteine biosynthetic process from serine−200
59SPD_2055 (guaB)Inosine-5′-monophosphate dehydrogenaseGMP biosynthetic process−4.3
60SPD_0309 (luxS)S-ribosylhomocysteinaseQuorum sensing (autoinducer-2)−8.1
61SPD_1677 (rafE)Sugar ABC transporter, sugar-binding proteinTransport2.43
62SPD_0427 (lacG-1)6-phospho-beta-galactosidaseLactose catabolic process via tagatose-6-phosphate138.73
63SPD_0777 (thiI)Probable tRNAsulfurtransferaseThiamine biosynthetic process2.60
64SPD_0874 (glmU)Bifunctional protein GlmUCell wall organization84.33
65SPD_0877 (mtnN)5′-methylthioadenosine/S-adenosylhomocysteine nucleosidaseMethylthioadenosine nucleosidase activity171.33
66SPD_1133 (pyrB)Aspartate carbamoyltransferasede novo' pyrimidine nucleobase biosynthetic process2.02
Figure 7

KEGG pathway analysis of genes downregulated in Streptococcus pneumoniae D39ΔluxS biofilms compared with the D39 wild-type biofilms.

List of differentially expressed genes in biofilms of the Streptococcus pneumoniae D39luxS mutant strain compared with the wild-type D39. KEGG pathway analysis of genes downregulated in Streptococcus pneumoniae D39ΔluxS biofilms compared with the D39 wild-type biofilms. The functional annotation of the differentially regulated genes in D39ΔluxS and D39 wild-type revealed that the genes involved in DNA replication and repair, ATP synthesis, capsule biosynthesis, cell division and the cell cycle, signal transduction, transcription regulation, competence, virulence, and fructose, lactose and galactose metabolism were down-regulated in the absence of LuxS/AI-2. The fold changes in gene expression in D39ΔluxS compared with the D39 wild-type from three independent samples are shown in Table 2. Galactose metabolism involves the tagatose-6-phosphate and Leloir pathways. Our results revealed that the tagatose-6-phosphate pathway genes (lacA, lacB, lacC, lacD, and lacG-2), and the Leloir pathway (galM) gene were significantly downregulated in D39ΔluxS. However, the lacG-1 gene was upregulated. Furthermore, lacE2 (encoding the PTS system, lactose-specific IIBC components), bgaC (encoding beta-galactosidase 3), and fucU (encoding RbsD/FucU transport protein family) were also significantly downregulated. The cps2A, cps2B, cps2C, cps2D, cps2E, cps2T, and cps2G genes involved in pneumococcal capsule synthesis were significantly downregulated in the D39ΔluxS. Similarly, the gene expression levels of the genes encoding DNA replication (dnaN), DNA repair (recJ, recA, and ogt), and ABC transportation (aliA, aliB, livM, and rafE) were downregulated in the D39ΔluxS. The xth and rnr genes encoding exodeoxyribonuclease III and ribonuclease R were also downregulated. Furthermore, the luxS gene mutation downregulated the transcription of regulatory protein-encoding genes such as ciaR, comX2, blpR, vncR, and pyrR, and ATP synthesis genes (atpF and atpE). The ciaR gene encodes a DNA-binding response regulator protein of the two-component regulatory system known as CiaH/CiaR, which is involved in the early steps of competence regulation (Guenzi et al., 1994), and the comX2 gene encodes a sigma factor that functions as a competence-specific global transcription modulator involved in bacterial competence.

Gene expression analysis using real-time RT-PCR

To validate the microarray results, real-time RT-PCR was performed on 15 differentially expressed genes. The 16S rDNA gene was included as a control. The fold changes in gene expression were calculated after normalization of each gene to 16S gene expression levels using the comparative threshold method. The real-time RT-PCR results agree with the microarray shown in Table 3.
Table 3

Fold changes in the gene expression of a Streptococcus pneumoniae luxS mutant strain (D39ΔluxS) during biofilm growth compared with the parental wild-type strain, detected by real-time polymerase chain reaction (PCR).

GenesFold change inD39ΔluxS
ply1.95
lytA2.2
ccpA0.5
lacG-20.4
rnr0.64
argG1.25
comX20.35
mtnN10.35
bplU0.21
cysK0.19
sufB0.24
aliA0.17
ciaR0.27
glmU2.5
rafE6.6
Fold changes in the gene expression of a Streptococcus pneumoniae luxS mutant strain (D39ΔluxS) during biofilm growth compared with the parental wild-type strain, detected by real-time polymerase chain reaction (PCR).

Discussion

Streptococcus pneumoniae asymptomatically colonizes the nasopharyngeal cavity in the form of structures called biofilms (Moscoso and García, 2009). However, bacteria from these biofilms can disperse to other typically sterile sites and causes diseases of the lungs (pneumonia), middle ear (OM), brain (meningitis), and blood (bacteremia) (Hava et al., 2003). The biofilm growth of S. pneumoniae is in part regulated by the LuxS/AI QS system (Vidal et al., 2011). Moreover, Trappetti et al. (2011c) reported that LuxS regulates pneumococcal biofilm formation, competence, and fratricide (Trappetti et al., 2011c). However, the effects of luxS mutation on global gene expression in pneumococcal biofilms and colonization capability in the middle ear were previously unknown. In the present study, we investigated the effect of S. pneumoniae luxS gene mutation on in vitro biofilm formation capability and colonization of the rat middle ear mucosa as well as global gene expression in biofilms. Vidal et al. (2011) detected low in vitro biofilm capability in D39ΔluxS compared with its parental D39 wild-type strain (Vidal et al., 2011). Herein, we showed that D39ΔluxS was unable to form robust early (6–12-h) and late (18–24-h) biofilms. The D39ΔluxS biofilms had ~60% less biomass and lower viable bacterial counts. LuxS/AI-2 QS is vital for in vitro pneumococcal biofilm growth, and in vivo colonization and pathogenesis. In S. pneumoniae, AI-2 synthesis from methionine occurs in the activated methyl cycle (AMC), which involves MTA/SAH nucleosidase (Pfs) and LuxS (Parveen and Cornell, 2011). MTA/SAH nucleosidase (Pfs) produces SRH, which is further cleaved by LuxS into homocysteine and 4,5-dihydroxy-2,3-pentanedione, the precursor of AI-2. Herein, we detected increased expression levels of the MTA/SAH nucleosidase-encoding gene, indicating an imbalance due to inactivation of LuxS and high MTA/SAH nucleosidase expression. The products of AMC—such as MTA, SAH, and 5′-deoxyadenosine (5′dADO)—are toxic and product inhibitors that need to be removed for normal growth (Parveen and Cornell, 2011). Therefore, it can be assumed that the low biofilm capability of the luxS mutant strain could be caused by the attenuation of AI-2 synthesis and an imbalance in the methionine pathway or AMC due to the accumulation of product inhibitors (Halliday et al., 2010; Vidal et al., 2013). Another interesting finding was the presence of low levels of EPS in the D39ΔluxS biofilms. Although we did not quantify the EPS present in the biofilms, the SEM images revealed that the D39ΔluxS biofilms were devoid of EPS, and the bacteria were scattered on the plate. Pneumococci typically colonize the nasopharyngeal cavities of young children and elderly people. However, under immune-suppressed conditions, these bacteria can disperse to other sterile sites, such as the middle ear, and cause OM. Disease severity depends on the successful colonization of the middle ear mucosa by S. pneumoniae. Our in vivo results demonstrated that D39ΔluxS was less capable of colonizing the rat middle ear mucosa than the wild-type strain. Significantly (> 60%) fewer bacteria were recovered from the rat middle ears inoculated with D39ΔluxS compared with the ears inoculated with the D39 wild-type strain. These results indicate that a loss of luxS renders bacteria unfit for successful colonization of the rat mucosal membrane. The results also indicate that in S. pneumoniae, LuxS plays an important role in the colonization of the rat middle ear, causing OM. Using a pneumonia model, it has been demonstrated that a less virulent luxS mutant strain is less likely to spread to the lungs and blood (Stroeher et al., 2003). Previous studies have demonstrated that the LuxS QS system plays an important role in the persistence, virulence, and dissemination of S. pneumoniae (Stroeher et al., 2003; Joyce et al., 2004; Vidal et al., 2013). This QS system has been implicated in the persistence of pneumococci in the mouse nasopharynx (Joyce et al., 2004). In pneumococci, LuxS-mediated QS plays an important role in survival and fitness. QS is mediated by a small molecule called auto-inducer-2, which is synthesized by the product of the luxS gene in an AMC. The LuxS catalyzes the conversion of SRH to AI-2. Moreover, the LuxS enzyme is absent in humans, and could be an attractive target for novel therapeutic agents against S. pneumoniae. Our previous studies showed that blocking the auto-inducer synthesis pathway decreased pneumococcal colonization in the rat middle ear, as well as in vitro biofilm formation (Yadav et al., 2012a, 2014). Furthermore, it has been suggested that quorum sensing or auto-inducer activity inhibition may increase the success of antibiotic treatment by increasing the susceptibility of bacterial biofilms and/or by increasing host survival following infection (Wnuk et al., 2009; Brackman et al., 2011). To further investigate the effect of luxS mutation on global gene expression in biofilms, we performed a global gene expression analysis using a cDNA microarray. The expression analysis revealed 117 genes that were differentially expressed in D39ΔluxS compared with the D39 wild-type. A large number of genes (60) encoding putative proteins were significantly downregulated, whereas only 6 genes were significantly upregulated. The downregulation of genes encoding DNA replication, repair, cell division, and cell wall protein biosynthesis in the luxS mutant indicates that cell division may be perturbed, which results in reduced in vitro biofilm formation and in vivo colonization capability. Interestingly, a large number of genes encoding ribosomal proteins were downregulated; however, the expression levels were <2-fold (data not shown). In S. pneumoniae, the CSP-mediated QS system plays an important role in biofilm growth, genetic competence, and pathogenesis. The CSP-mediated QS competence system includes the two-component regulatory system CiaH-CiaR, early competence genes (comAB and comCD), and the late competence gene comX (which encodes a global transcription modulator; Ishii et al., 2017). In the present study, we detected a significant reduction in the expression levels of the ciaR gene (which encodes the DNA-binding response regulator protein of the two-component regulatory system CiaH/CiaR), and the late competence comX2 gene. Recently, it has been reported that a ciaR gene mutant of Streptococci sanguinis was unable to form robust biofilms (Zhu et al., 2017). In S. pneumoniae, the ComX alternative sigma factor plays an important role in the initiation of the transcription of the late competence-specific operon, which facilitates DNA uptake and the recombination of DNA (Lee and Morrison, 1999; Luo and Morrison, 2003). Moreover, it has been reported that competence QS plays an important role in biofilm formation, and a ciaR/H gene mutant strain is unable to form biofilms (Trappetti et al., 2011b). The two ABC transporter genes aliA and aliB were downregulated in the luxS mutant (which encodes the Ami-AliA/AliB oligopeptide permease, an ATP-binding cassette transporter that is involved in nutrient uptake). It has been reported that the expression of aliA and aliB genes is required for nasopharyngeal cavity colonization, and the mutant strain is unable to colonize in vivo (Kerr et al., 2004). The pneumococcal capsule is a major virulence factor, and protects bacteria by interfering with the phagocytic activity of the host (Hyams et al., 2010). The pneumococcal capsule is composed of immunogenic capsular polysaccharides (CPSs) that are encoded by the cpsABCD genes (Guidolin et al., 1994; Feldman and Anderson, 2014). In the present study, microarray analysis revealed significantly reduced expression levels of cps2A, cps2B, cps2C, cps2D, cps2E, cps2T, and cps2G in the D39ΔluxS strain compared with the corresponding levels in the D39 wild-type strain. It has been suggested that mutation in each of the cpsABCD genes results in a significant reduction in capsule synthesis, as well as reduced virulence and decreased bacterial colonization of the nasopharyngeal cavity (Bender et al., 2003; Morona et al., 2004, 2006). Therefore, blocking LuxS activity probably reduces virulence and renders the bacteria vulnerable to the opsonophagocytic activity of the host (Kim et al., 1999). The ATP synthesis genes atpF and atpE were downregulated in the D39ΔluxS strain. Membrane-associated F0F1 H+-ATPase is essential for bacteria, and in S. pneumoniae, the primary roles of this enzyme are to create a proton gradient using the energy provided by ATP hydrolysis, and to maintain intracellular pH via proton extrusion (Martín-Galiano et al., 2001). In S. pneumoniae, the activity of the F0F1 ATPase increases as the pH of the growth medium decreases. Regulation of this pH-inducible phenotype occurs at the level of transcription initiation (Martín-Galiano et al., 2001). In streptococci, the F0F1 H+-ATPase-encoding operon is atpEBFHAGDC, and the F0 gene order is atpEBF (Shabayek and Spellerberg, 2017). In the present study our results demonstrated the downregulation of galactose pathway genes, such as lacB, lacC, lacD, and lacA (of the T6P pathway), and galM (of the Leloir pathway) in the D39ΔluxS strain (Figure 8). In addition, lacE2 (encoding the PTS system, lactose-specific IIBC components), bgaC (encoding beta-galactosidase 3), and fucU (encoding the RbsD/FucU transport protein family) were also downregulation in D39ΔluxS. Pneumococci can utilize various carbohydrate sources during colonization of the nasopharyngeal cavity (Buckwalter and King, 2012; Yadav et al., 2013). It has been reported that galactose catabolic route genes such as lacAB and lacD (of the T6P pathway) and galM (of the Leloir pathway) are required for pneumococcal colonization, and were upregulated during bacteria growth on mucin (Paixão et al., 2015). Furthermore, it has been suggested that lacD (T-6-p) or the Leloir pathway mutant D39 are less capable of colonizing the murine nasopharynx and have reduced virulence (Paixão et al., 2015). Recently, Trappetti et al. (2017) suggested that LuxS/AI-2 signaling enables pneumococci to utilize galactose as a carbon source, and enhances capsular polysaccharide production and the hyper-virulent phenotype (Trappetti et al., 2017). Present and previous study results demonstrate that the loss of functional LuxS hinders carbohydrate utilization, leading to the reduced colonization capability of pneumococci in vivo.
Figure 8

Schematic representation of galactose metabolism pathway in Streptococcus pneumoniae D39. In S. pneumoniae, lactose, and galactose are metabolized by the tagatose-6-phosphate pathway (light gray box) and the Leloir pathway (left; light pink box). The lacA, lacB, lacC, and lacD genes are involved in the tagatose-6-phosphate pathway, and the galM, galK, galT-1, and galE-2 genes are involved in the Leloir pathway. The lacE2 gene (which encodes the PTS system, lactose-specific IIBC component) is required for galactose transport. The lacA, lacB, lacC, lacD, galM, and lacE-2 genes were downregulated in the present study.

Schematic representation of galactose metabolism pathway in Streptococcus pneumoniae D39. In S. pneumoniae, lactose, and galactose are metabolized by the tagatose-6-phosphate pathway (light gray box) and the Leloir pathway (left; light pink box). The lacA, lacB, lacC, and lacD genes are involved in the tagatose-6-phosphate pathway, and the galM, galK, galT-1, and galE-2 genes are involved in the Leloir pathway. The lacE2 gene (which encodes the PTS system, lactose-specific IIBC component) is required for galactose transport. The lacA, lacB, lacC, lacD, galM, and lacE-2 genes were downregulated in the present study.

Conclusion

The results of this study demonstrate that the S. pneumoniae D39ΔluxS strain has a reduced ability to form early and late in vitro biofilm, and is less capable of colonizing the rat middle ear mucosa. LuxS/AI-2 regulates the expression of the genes involved in cell division and growth, capsule synthesis, carbohydrate metabolism, competence, virulence, and bacterial fitness during colonization.

Author contributions

MY, J-JS, S-WC, YG, SK and JV conceived and designed the experiments. MY and SK performed the experiments. MY, J-JS, S-WC, YG, and JV analyzed the data; S-WC, YG, J-JS, SK, and JV contributed reagents, materials, analysis tools. MY, J-JS, and JV wrote the paper.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  61 in total

Review 1.  Pneumococcus.

Authors:  Samuel Y Ash; John V L Sheffield
Journal:  Med Clin North Am       Date:  2013-04-29       Impact factor: 5.456

2.  Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo.

Authors:  Gilles Brackman; Paul Cos; Louis Maes; Hans J Nelis; Tom Coenye
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

3.  STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III.

Authors:  O T Avery; C M Macleod; M McCarty
Journal:  J Exp Med       Date:  1944-02-01       Impact factor: 14.307

4.  Transient association of an alternative sigma factor, ComX, with RNA polymerase during the period of competence for genetic transformation in Streptococcus pneumoniae.

Authors:  Ping Luo; Donald A Morrison
Journal:  J Bacteriol       Date:  2003-01       Impact factor: 3.490

5.  The LuxS-dependent quorum-sensing system regulates early biofilm formation by Streptococcus pneumoniae strain D39.

Authors:  Jorge E Vidal; Herbert P Ludewick; Rebekah M Kunkel; Dorothea Zähner; Keith P Klugman
Journal:  Infect Immun       Date:  2011-08-08       Impact factor: 3.441

Review 6.  Otitis media.

Authors:  Michael E Pichichero
Journal:  Pediatr Clin North Am       Date:  2013-04       Impact factor: 3.278

7.  The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms.

Authors:  Catherine Hyams; Emilie Camberlein; Jonathan M Cohen; Katie Bax; Jeremy S Brown
Journal:  Infect Immun       Date:  2009-11-30       Impact factor: 3.441

8.  Relationship between cell surface carbohydrates and intrastrain variation on opsonophagocytosis of Streptococcus pneumoniae.

Authors:  J O Kim; S Romero-Steiner; U B Sørensen; J Blom; M Carvalho; S Barnard; G Carlone; J N Weiser
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

9.  Interkingdom signaling induces Streptococcus pneumoniae biofilm dispersion and transition from asymptomatic colonization to disease.

Authors:  Laura R Marks; Bruce A Davidson; Paul R Knight; Anders P Hakansson
Journal:  MBio       Date:  2013-07-23       Impact factor: 7.867

10.  Autoinducer 2 Signaling via the Phosphotransferase FruA Drives Galactose Utilization by Streptococcus pneumoniae, Resulting in Hypervirulence.

Authors:  Claudia Trappetti; Lauren J McAllister; Austen Chen; Hui Wang; Adrienne W Paton; Marco R Oggioni; Christopher A McDevitt; James C Paton
Journal:  mBio       Date:  2017-01-24       Impact factor: 7.867

View more
  17 in total

1.  LuxS/AI-2 Quorum Sensing System in Edwardsiella piscicida Promotes Biofilm Formation and Pathogenicity.

Authors:  Yongcan Sun; Yu Li; Qian Luo; Jinjing Huang; Jiakang Chen; Ruiqing Zhang; Xuepeng Wang
Journal:  Infect Immun       Date:  2020-04-20       Impact factor: 3.441

2.  Comparison of specific in-vitro virulence gene expression and innate host response in locally invasive vs colonizer strains of Streptococcus pneumoniae.

Authors:  Naoko Fuji; Michael E Pichichero; Ravinder Kaur
Journal:  Med Microbiol Immunol       Date:  2021-03-22       Impact factor: 3.402

Review 3.  Modulation of quorum sensing-associated virulence in bacteria: carbohydrate as a key factor.

Authors:  Sarika Suresh; Prathiksha Prabhakara Alva; Ramya Premanath
Journal:  Arch Microbiol       Date:  2021-02-28       Impact factor: 2.552

4.  Hemoglobin Induces Early and Robust Biofilm Development in Streptococcus pneumoniae by a Pathway That Involves comC but Not the Cognate comDE Two-Component System.

Authors:  Fahmina Akhter; Edroyal Womack; Jorge E Vidal; Yoann Le Breton; Kevin S McIver; Shrikant Pawar; Zehava Eichenbaum
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

5.  Effect of childhood vaccination and antibiotic use on pneumococcal populations and genome-wide associations with disease among children in Nepal: an observational study.

Authors:  Rama Kandasamy; Stephanie Lo; Meeru Gurung; Michael J Carter; Rebecca Gladstone; John Lees; Sonu Shrestha; Stephen Thorson; Sanjeev Bijukchhe; Madhav C Gautam; Reetu Shrestha; Sunaina Gurung; Bibek Khadka; Lesley McGee; Robert F Breiman; David R Murdoch; Dominic F Kelly; Shrijana Shrestha; Stephen D Bentley; Andrew J Pollard
Journal:  Lancet Microbe       Date:  2022-05-09

Review 6.  Detection of Quorum-Sensing Molecules for Pathogenic Molecules Using Cell-Based and Cell-Free Biosensors.

Authors:  Craig Miller; Jordon Gilmore
Journal:  Antibiotics (Basel)       Date:  2020-05-16

Review 7.  Interference With Quorum-Sensing Signal Biosynthesis as a Promising Therapeutic Strategy Against Multidrug-Resistant Pathogens.

Authors:  Osmel Fleitas Martínez; Pietra Orlandi Rigueiras; Állan da Silva Pires; William Farias Porto; Osmar Nascimento Silva; Cesar de la Fuente-Nunez; Octavio Luiz Franco
Journal:  Front Cell Infect Microbiol       Date:  2019-02-05       Impact factor: 5.293

8.  Lactoferrin Disaggregates Pneumococcal Biofilms and Inhibits Acquisition of Resistance Through Its DNase Activity.

Authors:  Uriel A Angulo-Zamudio; Jorge E Vidal; Kamran Nazmi; Jan G M Bolscher; Claudia Leon-Sicairos; Brenda S Antezana; Adrián Canizalez-Roman; Nidia León-Sicairos
Journal:  Front Microbiol       Date:  2019-10-18       Impact factor: 5.640

9.  The Quorum Sensing Auto-Inducer 2 (AI-2) Stimulates Nitrogen Fixation and Favors Ethanol Production over Biomass Accumulation in Zymomonas mobilis.

Authors:  Valquíria Campos Alencar; Juliana de Fátima Dos Santos Silva; Renata Ozelami Vilas Boas; Vinícius Manganaro Farnézio; Yara N L F de Maria; David Aciole Barbosa; Alex Tramontin Almeida; Emanuel Maltempi de Souza; Marcelo Müller-Santos; Daniela L Jabes; Fabiano B Menegidio; Regina Costa de Oliveira; Tiago Rodrigues; Ivarne Luis Dos Santos Tersariol; Adrian R Walmsley; Luiz R Nunes
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

10.  Asian Sand Dust Particles Increased Pneumococcal Biofilm Formation in vitro and Colonization in Human Middle Ear Epithelial Cells and Rat Middle Ear Mucosa.

Authors:  Mukesh Kumar Yadav; Yoon Young Go; Sung-Won Chae; Moo Kyun Park; Jae-Jun Song
Journal:  Front Genet       Date:  2020-04-24       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.